MoonLake Immunotherapeutics
Venta netaMLTX·US·🇺🇸 US
0%compras·100%ventas
30 transacciones$0Total compras·0 compras
$629.6MTotal ventas·30 ventas
1010 insiders
Último: 31 mar 2026
| Fecha | Insider | Tipo | Valor | |
|---|---|---|---|---|
| 10 abr+1j | Bodenstedt Matthias·Class A ordinary shares, par value $0.0001 per share | VentaP | $38K | |
| 9 abr+2j | Bodenstedt Matthias·Class A ordinary shares, par value $0.0001 per share | VentaP | $1.6M | |
| 31 mar+2j | LAMPERT MARK NBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | LAMPERT MARK NBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | LAMPERT MARK NBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BVF INC/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BVF INC/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BVF INC/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BVF GP HOLDINGS LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BVF GP HOLDINGS LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BVF GP HOLDINGS LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BVF Partners OS Ltd.BOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BVF Partners OS Ltd.BOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BVF Partners OS Ltd.BOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | Biotechnology Value Trading Fund OS LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | Biotechnology Value Trading Fund OS LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | Biotechnology Value Trading Fund OS LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BVF II GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BVF II GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BVF II GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BIOTECHNOLOGY VALUE FUND II LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BIOTECHNOLOGY VALUE FUND II LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BIOTECHNOLOGY VALUE FUND II LPBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BVF I GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BVF I GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BVF I GP LLCBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BIOTECHNOLOGY VALUE FUND L PBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M | |
| 31 mar+2j | BIOTECHNOLOGY VALUE FUND L PBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $26.3M | |
| 31 mar+2j | BIOTECHNOLOGY VALUE FUND L PBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $32.4M | |
| 31 mar+2j | BVF PARTNERS L P/ILBOARD MEMBER·Class A Ordinary Shares, $0.0001 par value | Venta | $4.2M |